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Abstract Nucleotide sugar transporters deliver nucleo-
tide sugars into the Golgi apparatus and endoplasmic
reticulum. This study aimed to further characterize
mammalian UDP-galactose transporter (UGT) in MDCK
and CHO cell lines. MDCK-RCA
r and CHO-Lec8
mutant cell lines are defective in UGT transporter,
although they exhibit some level of galactosylation.
Previously, only single forms of UGT were identified in
both cell lines, UGT1 in MDCK cells and UGT2 in CHO
cells. We have identified the second UGT splice variants in
CHO (UGT1) and MDCK (UGT2) cells. Compared to
UGT1, UGT2 is more abundant in nearly all examined
mammalian tissues and cell lines, but MDCK cells exhibit
different relative distribution of both splice variants.
Complementation analysis demonstrated that both UGT
splice variants are necessary for N-a n dO-glycosylation of
proteins. Both mutant cell lines produce chondroitin-4-
sulfate at only a slightly lower level compared to wild-type
cells. This defect is corrected by overexpression of both
UGT splice variants. MDCK-RCA
r mutant cells do not
produce keratan sulfate and this effect is not corrected by
either UGT splice variant, overexpressed either singly or in
combination. Here we demonstrate that both UGT splice
variants are important for glycosylation of proteins. In
contrast to MDCK cells, MDCK-RCA
r mutant cells may
possess an additional defect within the keratan sulfate
biosynthesis pathway.
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Abbreviations
ER Endoplasmic reticulum
NST Nucleotide sugar transporter
UGT UDP-galactose transporter
UGT1 UDP-galactose transporter splice variant 1
localized to the Golgi apparatus
UGT2 UDP-galactose transporter splice variant 2
localized to the Golgi apparatus and ER
Introduction
Cellular glycoconjugates play a variety of fundamental
roles in the growth and development of eukaryotes, as well
as in the cell surface recognition of hosts by pathogens. The
glycan moiety is synthesized and modified by glycosyl-
transferases located in the lumen of the endoplasmic
reticulum (ER) and Golgi apparatus. The substrates
required by glycosyltransferases are sugars activated by
the addition of a nucleoside mono- or diphosphate
(UDP, GDP, or CMP). Nucleotide sugars are synthesized
in the cytosol [1], except for CMP-sialic acid, which is
synthesized in the nucleus [2]. To be available for
glycosyltransferases, they must be transported into the
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nucleotide sugar transporters (NSTs) [for reviews see
3–5], which are hydrophobic proteins with a molecular
weight of 30–45 kDa. Most predictions determine in these
multitransmembrane-spanning proteins an even number of
spans, which results in the N and C termini being directed
to the cytosolic side of the membrane. Membrane
topology has been determined for the murine CMP-sialic
acid transporter only and, in contrast to the theoretically
predicted eight transmembrane domains, ten transmem-
brane domains have been experimentally identified [6].
NSTs function in the form of dimers [6–10]o rh i g h e r
oligomers [11]. It has been demonstrated that they act as
antiporters, exchanging the nucleotide sugar with the
corresponding nucleoside monophosphate, which is a
product of the glycosylation reaction [3–5].
The first characterized NSTs were specific for the translo-
cation of a single nucleotide sugar [for review see 4, 5].
Recently, multisubstrate transporters of nucleotide sugars
have been described in several organisms, including
Leishmania donovani [11], Drosophila melanogaster
[12–14], Entamoeba histolytica [15], Caenorhabditis elegans
[16–18], and humans [19–21].
UDP-galactose transporting activity has been reported in
several organisms [16, 22–29]. Detailed characterization of
UDP-galactose transporter (UGT) was possible after mutant
cell lines, such as MDCK-RCA
r [28, 29], CHO Lec-8 [25,
30–32], and Had-1 [33], had been generated. Nonsense
mutations identified in the mutant cells cause inhibition of
UGT production, resulting in macromolecules deficient in
galactose [28, 30–38]. Complementation of this defect
results in reconstituted UDP-galactose transport. Expression
of recombinant UGT in mammalian and yeast cells also
confirmed its localization and specificity [22, 24, 26, 27].
Previously, two UGT (SLC35A2) isoforms (UGT1 and
UGT2) have been identified in humans [22, 24], but only
single orthologs have been found in the CHO cell line [25],
MDCK cell line [34], and in mouse [35]. The mouse and
MDCK UGTs resembled human UGT1, while the CHO
gene encoded a protein most homologous to human UGT2.
The human UGT gene contains five exons, with stop
codons in exons 4 and 5 [25]. Translation of exons 1 to 4
results in UGT1. If a splice consensus motif present in exon
4 is used, exon 5 becomes fused to the 5′ region of exon 4,
and UGT2 is translated. Although NSTs have been
mainly identified in the Golgi apparatus, those located
in the ER have also been characterized, including UDP-
N-acetylglucosaminetransporterofSaccharomyces cerevisiae
[39–41]o rU G To fSchizosaccharomyces pombe and S.
cerevisiae [41]. It has been shown that UGT1-like isoform
localizes to the Golgi apparatus, whereas UGT2-like isoform
localizes to both the Golgi apparatus and ER [42]. Analysis
of both UGT splice variants has demonstrated that
differences in human UGT isoforms are confined to the C
terminus. The dilysine motif present at the C terminus
o fU G T 2h a sb e e ns h o w nt ob er e s p o n s i b l ef o ri t sd u a l
localization [25, 42]. In the MDCK cell line, in both wild-
type and mutant cells, as well as in canine leukocytes, an
additional shorter UGT isoform has also been identified
and characterized [34]. It contains an in-frame 183-bp
deletion close to the N terminus of the UGT. In contrast,
this splice variant has not been found in human cell lines
(i.e. HL-60, HeLa), human tissues or the CHO cell
line [34].
In an attempt to further characterize the UDP-
galactose transporter, we identified the second UGT
splice variant in CHO (UGT1-like isoform) and MDCK
(UGT2-like isoform) cell lines and examined glycosylation
profiles of the wild-type and mutant MDCK-RCA
r and
CHO-Lec8 cells before and after phenotypic correction by
overexpression of the respective human UGT isoforms.
This allowed comparison of both UGT splice variants’
involvement in glycosylation of macromolecules.
Materials and methods
Rapid amplification of cDNA ends (RACE)
NucleoSpin RNA II Kit (Macherey-Nagel) was used to
purify total RNA from MDCK and CHO cells. The
concentration of purified RNA was determined spectropho-
tometrically at 260 nm. The quality and quantity of purified
RNA were further examined using an Agilent 2100
Bioanalyzer equippedwithRNAChip(AgilentTechnologies)
(Supplementary Fig. S1). RACE was performed using the
GeneRacer Kit (Invitrogen). One nested PCR with MDCK
cDNA and two nested PCRs with CHO cDNA were
performed to isolate specific products encoding UGT splice
variants. Analysis of sequences coding for other proteins was
carried out using the same procedure. Primers used in this
experiment are listed in Table 1. OptiTaq polymerase (Eurx)
was used in all reactions. RACE fragments were purified,
ligated to pJet1.2 Blunt Vector (CloneJet PCR Cloning Kit,
Fermentas) and sequenced (Genomed).
Reverse transcription-polymerase chain reaction (RT-PCR)
For RT-PCR reactions, Titan One Tube RT-PCR System
(Roche) was used. As templates, total RNA samples
obtained from 20 human tissues (Ambion), total RNA
purified from 9 human cell lines, Madin-Darby canine
kidney II (MDCK) and Chinese hamster ovary (CHO) cell
lines were used. The concentration of purified RNA was
determined spectrophotometrically at 260 nm. The quality
and quantity of purified RNA were further examined using
482 Glycoconj J (2011) 28:481–492an Agilent 2100 Bioanalyzer equipped with RNA Chip
(Supplementary Fig. S1). All RNA samples isolated from
cell lines were digested with DNase. RNA samples derived
from human tissues, purchased from Ambion, were
certified as DNA free. Expression levels of beta-2-
microglobulin (B2M) as a housekeeping gene were deter-
mined [43]. Because two human cell lines did not produce
its transcript, expression levels of glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) were determined
[43]. Primers used in this experiment are listed in Table 1.
Primers used to amplify UGT splice variants in CHO and
MDCK cells were designed to have identical or almost
identical Tm and G+C contents (Table 1), which resulted in
specific, distinct products at desired lengths after RT-PCR.
After initial denaturation (65°C, 5 min), RT was carried out
using 1 μg of total RNA at 55°C for 30 min. Amplified
DNA fragments specific for UGT1 and UGT2 were
synthesized for 30 cycles of PCR at 94°C for 15 s
(denaturation), 55°C for 30 s (annealing), and 68°C for
1 min (elongation), separated in 1.4% agarose gel and
visualized with ethidium bromide.
Construction of mammalian expression plasmids
Open reading frames (ORFs) of human UGT1 and UGT2
(both containing stop codons) with appropriate restriction
sites at both ends were amplified using cDNA synthesized
from 5 μg of total RNA as a template. RNA was isolated
from 2×10
6 HL-60 cells using the NucleoSpin RNA II Kit.
For the RT reaction, the Thermoscript 1st Strand Synthesis
Kit (Invitrogen) and oligo dT(20) were used in conditions
recommended by the manufacturer. Constructs containing
the FLAG epitope at the N terminus were prepared by
ligation of UGT1 and UGT2 encoding sequences into
3xFLAG-myc-CMV-26 (Sigma). For pVitro1-neo plasmid
(InvivoGen), first adaptors encoding 6His-c-myc epitopes
(MCS1) and 6His-HA epitopes (MCS2) were ligated. All
adaptors were prepared from sense and antisense oligonu-
cleotides (Genomed) purified using denaturing polyacryl-
amide gel electrophoresis and annealed at an initial
temperature of 80°C with slow cooling down (1°C per
min) to 35°C in 0.5 M NaCl. Sequences of adaptor
oligonucleotides and primers for amplification of ligated
ORFs are available upon request. Constructs containing
short epitopes at the start of each polylinker were used for
ligation of UGT1 and UGT2 encoding sequences. All
ligations were performed using the Rapid DNA Ligation
Kit (Fermentas). Additional sequences attached to the N
terminus of UGT1 and UGT2 proteins contain the
respective epitopes and amino acid residues resulting from
the addition of sequences for respective restriction enzymes
(3xFLAG: MDYKDHDGDYKDHDIDYKDDDDKL,
6His-c-myc: MAHHHHHHASEQKLISEEDLIKDPN,
6His-HA: MAHHHHHHASYPYDVPDYAPEYTDPN).
All plasmids constructed in this study are listed in
Table 2.
Table 1 Primers used for 3′RACE reactions and RT-PCR
Primer Sequence (5′→3′) Description
3RacerCHOGal1 GGTGGGCTACTGGTGGCTGTTGTAGT 3′RACE CHO 1st primer
3RacerCHOGal2 CCTGGGCGCTGGGCTCGTCATTGG 3′RACE CHO 2nd primer
3RacerCHOGal3 CCTCTGCCTCTGGGCCCTGCATTCA 3′RACE CHO 3rd primer
3RacerMDCKGal1 GCTTCCACGTGGACCCATTGTTTGC 3′RACE MDCK 1st primer
3RacerMDCKGal2 GCCAAAGCCATAGCCTCCACCTCC 3′RACE MDCK 2nd primer
HsGalUni-F CTACTGGTGGCTGTGGTTGTC RT-PCR of human UGT splice variants
HsGalER-R GAACCCTTCACCTTGGTGAGC RT-PCR of human UGT2 splice variant
HsGalGolgi-R CCTCACTTCACCAGCACTGAC RT-PCR of human UGT1 splice variant
CfGalUni-F GGCTGCTGGTGGCTGTTGTCGT RT-PCR of MDCK UGT splice variants (Tm=60.4°C)
CfGalER-R CTACGAACCCTTCACCTTGGTGAGC RT-PCR of MDCK UGT2 splice variant (Tm=61°C)
CfGalGolgi-R TCACTTCACCAGCACTGACTTCGG RT-PCR of MDCK UGT1 splice variant (Tm=59.1°C)
CgGalUni-F GGCTACTGGTGGCTGTTGTAGTC RT-PCR of CHO UGT splice variants (Tm=58.8°C)
CgGalER-R CGAACCCTTCACCTTGGTGAGCA RT-PCR of CHO UGT2 splice variant (Tm=58.8°C)
CgGalGolgi-R GCTCTCACTTCACCAGCACTGAC RT-PCR of CHO UGT1 splice variant (Tm=58.8°C)
GAPDH-F TGCACCACCAACTGCTTAGC RT-PCR of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [43]
GAPDH-R GGCATGGACTGTGGTCATGAG RT-PCR of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) [43]
B2M-F TGCTGTCTCCATGTTTGATGTATCT RT-PCR of beta-2-microglobulin (B2M) [43]
B2M-R TCTCTGCTCCCCACCTCTAAGT RT-PCR of beta-2-microglobulin (B2M) [43]
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MDCK and MDCK-RCA
r mutant cells were grown in
minimum essential medium (MEM, Sigma-Aldrich) sup-
plemented with 10% fetal bovine serum, 2 mM L-
glutamine, 100 IU penicillin/ml and 100 μg/ml streptomycin
(Sigma-Aldrich). CHO and CHO-Lec8 mutant cells were
grown in MEM with alpha-modification (α-MEM, Sigma-
Aldrich), supplemented with 10% fetal bovine serum, 2 mM
L-glutamine, 100 IU penicillin/ml and 100 μg/ml streptomy-
cin. Alternatively, wild-type MDCK and MDCK-RCA
r
mutant cells were grown in EX-CELL MDCK serum-
free medium (Sigma-Aldrich) supplemented with 6 mM
L-glutamine, 100 IU penicillin/ml and 100 μg/ml
streptomycin. CHO and CHO-Lec8 mutant cells were grown
in SFM4CHO-A serum-free medium (Thermo Scientific)
supplemented with 4 mM L-glutamine, 100 IU penicillin/ml
and 100 μg/ml streptomycin. Cells were grown in a
humidified incubator (37°C, 5% CO2).
MDCK-RCA
r and CHO-Lec8 mutant cells were trans-
fected with expression plasmids (Table 2) using ESCORT™
IV Transfection Reagent (Sigma-Aldrich) according to the
manufacturer’s instructions. Stable transfectants were
selected in complete media containing 200 (MDCK)/150
(CHO) μg/ml zeocin or 600 (MDCK)/500 (CHO) μg/ml
G-418 sulfate (InvivoGen).
Cell lysis and protein determination
Cells adapted to serum-free culture conditions were
collected and lysed using Complete Lysis-M reagent
(Roche) supplemented with protease inhibitor cocktail and
1 mM EDTA according to the manufacturer’s instructions.
Protein concentration was determined using the modified
Bradford method [44].
Detection of epitope-tagged proteins by Western blotting
Aliquots containing 20 μg of total proteins were separated
by SDS-PAGE in 8% gels and transferred onto nitrocellu-
lose membranes (Whatman). For detection of the HA
epitope, membranes were blotted with a 1:1,000 dilution
of mouse horseradish peroxidase (HRP)-conjugated anti-
HA antibody (Roche). For detection of the FLAG epitope,
membranes were blotted with a 1:1,000 dilution of mouse
anti-FLAG monoclonal antibody (Sigma-Aldrich), followed
by incubation with a 1:10,000 dilution of HRP-conjugated
goat anti-mouse antibody (Promega). For detection of the
c-myc epitope, membranes were blotted with a 1:1,000
dilution of mouse anti-c-myc monoclonal antibody (Sigma-
Aldrich), followed by incubation with a 1:10,000 dilution
of HRP-conjugated goat anti-mouse antibody. Immunore-
active bands were visualized using the Western Lightning
Chemiluminescence Reagent Plus system (Perkin Elmer).
Analysis of glycoproteins with lectins
Aliquots containing 20 μg of total proteins extracted
from cells grown in respective serum-free media were
separated by SDS-PAGE in 8% gels and transferred onto
nitrocellulose membranes. After blocking with Carbo-Free
Blocking Solution (Vector Laboratories) membranes were
incubated with appropriate biotinylated lectins (Vector
Laboratories) in 50 mM Tris–HCl, pH 7.5, containing
150 mM NaCl (TBS), 0.2% Tween-20, 1 mM Mg
2+,
1m MC a
2+ a n d1m MM n
2+. Lectins bound to specific
glycans were subsequently detected using alkaline
phosphatase-conjugated avidin D (Vector Laboratories) and
visualized with NBT/BCIP solution (Roche) according to the
manufacturer’si n s t r u c t i o n s .
Isolation of N-glycans from MDCK and CHO cells
Cells (∼10
7) grown in respective serum-free media were
scraped from tissue culture plates, washed twice with 15 ml
of cold PBS and collected at 200×g for 5 min. Then, cells
were lysed on ice in 500 μl of lysis buffer (20 mM Tris–
HCl pH 7.4, 150 mM NaCl), containing 1% Nonidet NP-40
and Complete protease inhibitors (without EDTA) for 1 h.
After incubation in lysis buffer, samples were additionally
sonicated 3 times, each time with 30 s pulses and 2-min
cooling between pulses. Lysates were centrifuged at
18,000×g for 15 min at 4°C. Cleared supernatants were
used to isolate the total pool of glycoproteins. For this
Table 2 Plasmids constructed for generation of stably transfected cell lines
Plasmid used for transfection Original vector (source) Human UGT coding sequences cloned in MCS
HsUGTGolgi1 3xFLAG-myc-CMV-26 (Sigma) UGT1 splice variant with FLAG epitope at N-terminus
HsUGTGolgi2 pVitro1-neo (InvivoGen) MCS1: UGT1 splice variant with 6His-HA epitope at N-terminus
HsUGTER 3xFLAG-myc-CMV-26 (Sigma) UGT2 splice variant with FLAG epitope at N-terminus
HsUGTER/Golgi pVitro1-neo (InvivoGen) MCS1: UGT2 splice variant with 6His-HA epitope at N-terminus; MCS2:
UGT1 splice variant with 6His-c-myc epitope at N-terminus
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(Sigma) containing 300 μl of mixed beads (1:1, v/v)o f
WGA-agarose and ConA-agarose (Vector Laboratories).
Packed columns were washed 4 times with 500 μlo f
equilibration buffer (20 mM Tris–HCl pH 7.4, containing
1 M NaCl, 1 mM MnCl2, 1 mM CaCl2, 1 mM MgCl2),
each time for 1 min at 1,000×g. Cell lysates were loaded
onto columns and incubated for 30 min at 4°C with slow
rotation. After binding, columns were centrifuged at
1,000×g for 1 min and supernatants were discarded. Lectin
beads were washed 3 times with equilibration buffer, each
time for 10 min with slow rotation. Finally, glycoproteins
were released sequentially from lectin affinity gel with 2×
250 μl of equilibration buffer containing 500 mM α-
mannopyranoside (Sigma) and 2×250 μL of the same
buffer containing 800 mM N-acetylglucosamine (Sigma),
with 15-min incubation in each elution step. Glycoprotein
samples were concentrated to 50 μl by ultrafiltration using
Microcon 10 (Millipore). During this procedure, elution
buffer was changed to glycoprotein denaturation buffer
(N-glycosidase F deglycosylation enzyme pack, New
England Biolabs). Acetone precipitation of cellular proteins
was also performed as an alternative method to obtain
concentrated samples for subsequent deglycosylation.
Whole-cell lysate proteins were diluted to 2 mg/ml using
the lysis buffer and 500 μl aliquots were precipitated
overnight at −20°C with an equal volume of cold acetone.
After centrifugation at 10,000×g for 10 min, precipitates
were air-dried and resuspended in glycoprotein denaturation
buffer (N-glycosidase F deglycosylation enzyme pack).
Deglycosylation was performed according to the manufac-
turer’s protocol using 1 μl of the enzyme (500 U) and
incubation for 18 h at 37°C in deglycosylation buffer. Both
methods of glycoproteins isolation resulted in a similar
glycan pool. Released N-glycans were isolated on 50 mg
Hypercarb graphite SPE columns (Thermo Electron) using
the protocol described for GlycoClean H SPE columns I
(Glyko) and dried using a Maxi Dry Lyo (Heto). N-glycans
were fluorescently labeled with 2-aminobenzamide (2-AB)
according to the reported protocol [45] and purified on a
1-mm 3 MM blotting filter paper (Whatman) placed on the
bottom of an empty glass column (1 cm diameter) with the
procedure identical to the protocol described for Glyco-
Clean S cartridges (Glyko). Small fractions of all samples
(∼5–15%) were separated on a GlycoSep N normal-phase
column (Glyko) using the high salt solvent system (HSSS)
as previously described [46] and the Perkin Elmer Series
200 HPLC system (Perkin Elmer) equipped with a 200a
fluorescence detector (Perkin Elmer). Exoglycosidase
digestion was performed as previously described [46].
Reactions were performed sequentially in 50 μlo ft h e
universal buffer (0.1 M citrate-phosphate buffer, pH 5.5).
After first digestion with unspecific neuraminidase (New
England Biolabs), samples were filtered using Ultrafree MC
spin columns (Millipore). Membranes were washed twice
with 100 μl of Milli-Q water. Samples were dried and
resuspended in 100 μl of Milli-Q water. Half of the sample
volume (50 μl) was dried, dissolved in 10 μl of 70%
acetonitrile, and separated on a GlycoSep N column using
high-performance liquid chromatography (HPLC). The rest
of the sample was digested with 1-3,4 β-galactosidase
(New England Biolabs), filteredusinganUltrafreeMCspin
c o l u m n ,d r i e d ,re- sus pende d in 10 μl of 70% acetonitrile,
.and separated on a GlycoSep N column using HPLC.
Analysis of proteoglycans by Western blotting
Aliquots containing 20 μg of total proteins extracted from
cells grown in respective serum-free media were separated
by SDS-PAGE in 8% gels and transferred onto nitrocellu-
lose membranes (Whatman). For the detection of keratan
sulfate, membranes were blotted with a 1:10,000 dilution of
mouse anti-keratan sulfate monoclonal antibody (Chemicon),
followed by incubation with a 1:10,000 dilution of HRP-
conjugated goat anti-mouse antibody. For the detection
of chondroitin-4-sulfate, samples were subjected to prior
digestion with 0.2 U/ml of chondroitinase ABC from
Proteus vulgaris (Sigma-Aldrich) in 50 mM Tris–HCl,
containing 60 mM sodium acetate for 24 h at 37°C. After
digestion, which exposed the epitopes, aliquots containing
15 μg of proteins were separated by SDS-PAGE in 8%
gels and transferred onto nitrocellulose membranes.
Membranes were blotted with a 1:10,000 dilution of mouse
anti-chondroitin-4-sulfate monoclonal antibody (Chemicon),
followed by incubation with a 1:10,000 dilution of
HRP-conjugated goat anti-mouse antibody. Immunoreactive
bands were visualized usingt h eW e s t e r nL i g h t n i n g
Chemiluminescence Reagent Plus system.
Results and discussion
Identification of the second UGT isoform in MDCK
and CHO cell lines
Previously, two UGT isoforms (UGT1 and UGT2) have
been found in humans [22, 24], whereas only UGT2-like
isoform in the CHO cell line [25] and UGT1-like isoform in
the MDCK cell line [34] and in mouse [35] have been
identified. In this study, using a modified RACE technique,
we identified for the first time sequences of UGT1 and
UGT2-like splice variants in CHO and MDCK cells,
respectively [EMBL: FN825776, EMBL:FN825775]. It is
likely that former difficulties in the detection of the second
splice variant of UGT in cells other than human cells could
result from lower levels of the respective transcripts.
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mammalian cell, although ORFs are similar in length, the
transcript encoding the UGT2 version is significantly
shorter (∼1,500 bp) compared to the UGT1 version
(∼2,300 bp), the latter containing a longer non-coding 3′
region (∼1,200 bp for UGT1 compared to ∼300 bp for
UGT2). It seems that this may be a general feature of UGT
isoform coding sequences. In accordance with the pub-
lished data [25, 26] also the UGT2-like form found in
MDCK cells contained a dilysine motif at the C terminus
(LLTKVKGS).
Tissue distribution and expression of mammalian
UGT isoforms
Oelmann et al.[ 25] suggested that differences in UGT
isoform expression may reflect tissue- and/or species-
specific regulation processes. However, no studies have
been performed to support this hypothesis. To compare
tissue distribution of both UGT isoforms, both transcripts
were analyzed in 20 human tissues and 9 human cell lines
using two-step RT-PCR. To avoid potential amplification of
PCR products from DNA template, all RNA samples were
digested with DNase. In control PCR reactions carried out
with purified RNA as a template, no products were
detected. Primers were designed to give specific products
of the desired length from the cDNA template only. As
shown in Fig. 1a and b, abundant relative expression of the
UGT2 version, compared to the UGT1 version, was
observed in almost all tissues and cell lines examined. It
is likely that, compared to UGT2, the UGT1 variant may be
dominant in tissues characterized by intensive metabolism
(e.g. kidney, liver, or placenta) and/or tissues composed of
high levels of proteoglycans such as keratan sulfate (e.g.
trachea). Relative levels of mRNA encoding UGT1 and
UGT2 isoforms found in CHO cells were comparable and
similar to those found in several human tissues and cell
lines (Fig. 1c). In contrast, in MDCK cells a lower level of
mRNA encoding the UGT2 splice variant was observed
compared to the UGT1 transcript level (Fig. 1c). This
suggests that this cell line may exhibit distinct metabolism
of galactosylated macromolecules.
Analysis of glycoprotein glycosylation profiles
of MDCK and CHO wild-type and mutant cells
MDCK-RCA
r and CHO-Lec8 mutant cells are significantly
defective in the transport of UDP-galactose [22, 29, 36]. It
has been shown by lectin staining that both cell lines exhibit a
70–90% deficiency of galactose attached to glycoproteins,
glycolipids, and some proteoglycans [28–31, 36]. Glycopro-
teins produced in CHO-Lec8 and MDCK-RCA
r mutant cells
Fig. 1 Tissue distribution of mRNA encoding mammalian UGT splice
variants. mRNA levels were analyzed in selected human tissues (a),
selected human cell lines (b), and MDCK and CHO cell lines (c)u s i n g
RT-PCR. Resulting products were visualized in agarose gels with
ethidium bromide. RNA integrity was examined using an Agilent
Technologies Bioanalyzer (see Supplementary Fig. S1). Expression
levels of housekeeping genes, beta-2-microglobulin (B2M) or
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are shown.
Similar patterns were obtained in all reactions repeated at least two
times. UGT1 and UGT2, UDP-galactose transporter splice variants;
END and EEV, cell lines derived from normal human endometrium;
HL60, human promyelocytic leukemia cells; CaSki, human cervical
carcinoma cell line; A375, human melanoma cell line; HeLa, human
cervical carcinoma cell line; Hek293, human embryonic kidney cell
line; PC-3, human prostate cancer cell line; THP-1, human acute
monocytic leukemia cell line
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MDCK-RCA
r mutant cell lines. Mutant cells were stably transfected
with respective expression plasmids and UGT splice variants
expressed either singly (a and b) or in combination (c and d) were
identified using Western blotting with antibodies against epitopes as
follows: for single expression in CHO-Lec8 cells UGT1 and UGT2
contained the FLAG epitope; for single expression in MDCK-RCA
r
cells UGT1 contained the 6His-HA epitope and UGT2 contained the
FLAG epitope; for dual expression in CHO-Lec8 cells UGT1
contained the 6His-c-myc epitope and UGT2 contained the 6His-HA
epitope; and for dual expression in MDCK-RCAr cells UGT1
contained the 6His-c-myc epitope and UGT2 contained the 6His-HA
epitope. Numbers indicate positive clones expressing the respective
proteins obtained in representative experiments. Data presented in this
study were obtained from experiments using clones indicated with an
asterisk. C, control cells transfected with empty vector
Fig. 3 Lectin staining of glycoproteins derived from wild-type
MDCK and CHO and mutant MDCK-RCA
r and CHO-Lec8 cells.
Mutant cells were stably transfected with respective expression
plasmids and UGT splice variants were expressed either singly or in
combination. Proteins were extracted as described in Materials and
Methods, separated by SDS-PAGE and transferred onto nitrocellulose
membranes. Phenotypic correction was determined using GSL II
(lectin from Griffonia simplicifolia) or VVL (lectin from Vicia villosa)
lectin. Reactivity of glycoproteins derived from protein cell extracts
with GSL II, lectin specific for terminal N-acetylglucosamine present
in both N-a n dO-glycans or with VVL, lectin specific for N-
acetylgalactosamine attached to O-glycans was visualized using
alkaline phosphatase-conjugated avidin D and NBT/BCIP. Control
cells transfected with empty vector gave similar results as mutant
cells. Representative data out of three sets with a similar pattern
are shown
Glycoconj J (2011) 28:481–492 487are also deficient in sialic acid, since this sugar is most often
attached to galactose residues. Detailed glycosylation
analysis has been performed in murine Had-1 mutant
cells and their parental FM3A cells [35], as well as in
CHO-Lec8 mutant cells [37, 38].
To date, the role of both splice variants of UGT in
galactosylation of macromolecules in CHO and MDCK
cells has not been reported. Therefore, in this study we
developed an experimental model of UGT functional
analysis using overexpression of both human splice
variants, singly or in combination, in the MDCK-RCA
r
and CHO-Lec8 mutant cells. Several clones expressing
native and N-tagged proteins, varying in expression levels of
respective UGT splice variants (Fig. 2 and data not shown),
were further examined in regard to phenotypic correction.
Results of phenotypic correction analyzed by lectin staining
were similar for each clone examined; therefore in this study
data for selected tagged UGTs (indicated in Fig. 2 with
asterisks), which can be easily monitored with antibodies,
were shown. All overexpressed proteins examined in this
study properly localized to the ER and/or Golgi apparatus
and transported UDP-Gal into Golgi vesicles (unpublished
data). To date, all analyses of glycoprotein glycosylation
have been performed using cells cultured in the presence of
serum [e.g. 32, 35, 37, 38]. In our preliminary studies we
found that serum glycoconjugates attached to the cell surface
were unable to be completely removed by washing, which
resulted in partial masking of endogenous glycosylation
profiles of the cells. Therefore, to analyze glycosylation
profiles of glycoproteins derived from the cells only, all cells
were cultured in serum-free medium. When the cells were
stably transfected with UGT coding sequences, the mutant
cells exhibited a phenotype similar to wild-type cells, as
analyzed by reactivity with specific lectins. As shown in
Fig. 4 N-glycan profiles of wild-type MDCK and CHO and mutant
MDCK-RCA
r and CHO-Lec8 cells. N-glycans were released from
glycoproteins using N-glycosidase F, fluorescently labeled with 2-AB,
and separated using the GlycoSep N column. a N-glycan profiles of
wild-type CHO or MDCK cells (black lines) and mutant CHO-Lec8 or
MDCK-RCA
r cells (red lines). b N-glycan profiles of CHO-Lec8 or
MDCK-RCA
r mutant cells (red lines) and the mutant cells expressing
UGT1 isoform (black lines). c N-glycan profiles of CHO-Lec8 or
MDCK-RCA
r mutant cells (red lines) and the mutant cells expressing
UGT2 isoform (black lines). d N-glycan profiles of CHO-Lec8 or
MDCK-RCA
r mutant cells (red lines) and the mutant cells expressing
both UGT1 and UGT2 isoforms (black lines). Control cells transfected
with empty vector gave similar results as mutant cells. Representative
data out of three sets with a similar pattern are shown. Fluorescence,
fluorescence detector response; Time, time [min]
488 Glycoconj J (2011) 28:481–492Fig. 3, analysis carried out with GSL II, a lectin specific for
terminal N-acetylglucosamine (GlcNAc) present in both N-
and O-glycans, resulted in more intense signals in mutant
cells, especially in CHO-Lec8 cells. This effect results from
increased levels of truncated oligosaccharide chains termi-
nated with GlcNAc in the mutant cells possessing lower
levels of galactose attached to oligosaccharide chains. In the
case of MDCK-RCA
r mutant cells, overexpression of the
UGT1 and/or UGT2 splice variant resulted in correction of
the N-glycosylation defect (Fig. 3). In contrast, CHO-Lec8
mutant cells regained a glycosylation pattern more similar to
wild-type cells after correction with both splice variants only.
This suggests that CHO cells require both UGTsplice variants
to perform proper galactosylation of glycoproteins. One may
conclude that more efficient correction in MDCK-RCA
r
mutant cells may result from the presence of the additional,
shorter version of UGT [34]. We previously found that
mRNA levels of this UGT variant were higher in the MDCK-
RCA
r mutant cells, which may additionally support the
involvement of this UGT variant in UDP-galactose transport.
Analysis with VVL, a lectin specific for N-acetylgalactos-
amine (GalNAc) attached to O-glycans, is shown in Fig. 3.
This sugar is more exposed in cells lacking proper
attachment of galactose to some types of O-glycans. The
effect of correction of the mutation effect in both mutant cell
lines was similar to that analyzed with GSL II, although the
intensity of the reaction was higher.
The second approach consisted of comparison of N-
glycosylation profiles of fluorescently labeled glycans
released from glycoproteins and separated on a GlycoSep N
column, which was calibrated with partially digested 2-AB
dextran. The normal-phase HPLC separates 2-AB-labeled
N-glycans based on differences in chain length, as shorter
oligosaccharides elute earlier than full-length structures. Data
shown in Fig. 4a (top panel) demonstrate differences in
glycosylation profiles observed between the wild-type CHO
and mutant CHO-Lec8 cells. Although the differences
between wild-type MDCK and mutant MDCK-RCA
r cells
are less significant, they are easily detectable (Fig. 4a,
bottom panel). One may conclude that this difference could
result from the presence of the additional, shorter splice
variant of UGT found only in MDCK cells, including the
mutant MDCK-RCA
r cells, which would participate in
galactosylation of macromolecules. Compared with the
wild-type cells, in both examined mutant cells truncated
oligosaccharides comprise the major pool of N-glycans.
This effect is similar to that demonstrated in Had-1 cells
[35]. Analysis of glycosylation profiles after phenotypic
correction of the mutant cells further demonstrated that
both UGT1 and UGT2 splice variants were able, at least in
part, to correct the galactosylation defect in both mutant cell
lines (Fig. 4b–d). This was visible in the increased pool of
more complex oligosaccharides.
To detect whether UGT is the only transporter responsible
for galactose delivery for subsequent galactosylation in
MDCK and CHO cells, we compared N-glycosylation
profiles of the mutant cells before and after galactosidase
treatment. Since sialic acid residues attached to the terminal
galactose may block galactosidase access, prior neuramini-
dase treatment was performed. After galactosidase treatment
a slight decrease in the range comprising higher-molecular-
weight glycans and a slight increase in the range comprising
lower-molecular-weight, truncated glycans were observed in
both mutant cells (data not shown). The effect was not
related to the specific type of glycans, suggesting that in the
mutant cells low galactose levels are still present in
N-glycans attached to glycoproteins. Previously, Hara et al.
[35] demonstrated that also in murine Had-1 mutant cells
lacking functional UGT some galactosylation occurs. All
these data indicate that an additional mechanism of UDP-Gal
transport from the cytosol to the Golgi apparatus may exist.
Although an alternative mechanism of UDP-galactose
transport in CHO-Lec8 mutant cells is not known, in
MDCK-RCA
r mutant cells the additional, shorter UGT form
[34] may support UDP-galactose transport, at least in part,
leading to partial galactosylation of glycoproteins.
Fig. 5 Analysis of proteoglycans produced in wild-type MDCK and
CHO and mutant MDCK-RCA
r and CHO-Lec8 cells. Mutant cells
were stably transfected with respective expression plasmids and UGT
splice variants were expressed either singly or in combination.
Proteoglycans present in protein cell extracts were separated by
SDS-PAGE in their native form (keratan sulfate) or after limited
digestion with chondroitinase (chondroitin-4-sulfate) and detected
with specific antibodies using Western blotting. Control cells trans-
fected with empty vector gave similar results as mutant cells.
Representative data out of three sets with similar pattern are shown
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Proteoglycans, which play a crucial role in chondrogenesis
and skeletal development, belong to a family of macro-
molecules composed of glycosaminoglycan chains of a
repeated disaccharide linked to a central core protein.
Within proteoglycans, keratan sulfate contains galactose in
long chains, whereas in other types of proteoglycans
(chondroitin and heparan sulfates) galactose moieties are
attached to the core part of the polysaccharide chain. To
examine involvement of the respective UGT splice variants
in proteoglycan synthesis, selected proteoglycans were
analyzed in MDCK-RCA
r and CHO-Lec8 mutant cells
subjected to phenotypic correction. It is worth noting that in
both mutant cell lines reactivity with antibodies against
chondroitin-4-sulfate was relatively high and only slightly
lower compared to the wild-type cells (Fig. 5). A similar
effect was demonstrated in radiolabeled MDCK cells [29].
Analysisofchondroitin-4-sulfatedemonstratedthatcorrection
of the mutant phenotype of CHO-Lec8 and MDCK-RCA
r
cells was observed after parallel overexpression of both UGT
splice variants, with the most pronounced effect observed in
CHO-Lec8 mutant cells (Fig. 5). These data suggest that in
synthesis of proteoglycans an additional UDP-galactose
transport mechanism may also exist.
CHO cells do not possess keratan sulfate [3, 29,a n d
our data not shown]; therefore we analyzed proteoglycans
using specific antibodies in MDCK cells only. As shown
in Fig. 5, MDCK-RCA
r mutant cells do not produce
keratan sulfate, and surprisingly, this effect was not
corrected by UGT splice variants overexpressed either
singly or in combination. It is likely that MDCK-RCA
r
mutant cells may possess an additional, not yet identified,
defect within the keratan sulfate biosynthesis pathway. To
exclude additional mutations in MDCK-RCA
r cells, we
examined in both MDCK and MDCK-RCA
r cells known
coding sequences or identified coding sequences for
several proteins involved in proteoglycan biosynthesis.
However, we were not able to identify a defect in the
coding sequences of analyzed mRNA. Analysis of
protein similar to sulfotransferase 1 (cloned, sequenced,
and submitted to database; EMBL ID: FR775794),
protein similar to sulfotransferase 6 (cloned, sequenced,
and submitted to database; EMBL ID: FR775795),
protein similar to beta-1,4-galactosyltransferase 4 (cloned,
sequenced, and submitted to database; EMBL ID:
AM989461), UDP-GlcNAc transporter (EMBL ID:
AF057365), UDP-GlcNAc:betaGal beta-1,3-N-acetylgluco-
saminyltransferase 2 (NCBI ID: XP_531841), and PAPS
transporter 1 (EMBL ID: EF568109) showed that all amino
acid sequences were identical in the wild-type and mutant
cells.
Conclusions
Both MDCK-RCA
r and CHO-Lec8 mutant cell lines serve
as widely used models to study UDP-galactose transport in
mammals. In this study we have identified the second UGT
splice variant in CHO (UGT1) and MDCK (UGT2) cells. It
is highly possible that UGT1 and UGT2 splice variants are
expressed in most (if not all) mammalian cells. We
demonstrated that both UGT splice variants are important
for glycosylation of proteins. In contrast to MDCK cells,
MDCK-RCA
r mutant cells do not produce keratan sulfate
and this effect was not corrected by UGT splice variants
overexpressed either singly or in combination. It is likely
that MDCK-RCA
r mutant cells may possess an additional,
not yet identified, defect within the keratan sulfate
biosynthesis pathway.
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